XML 87 R76.htm IDEA: XBRL DOCUMENT v3.21.1
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2021
May 01, 2020
Apr. 30, 2021
May 01, 2020
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,149,107 $ 929,398 $ 2,022,093 $ 1,696,881
Cost of Sales (746,154) (622,681) (1,304,104) (1,102,076)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (4,185) 2,480 (6,183) 4,017
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,149,107 929,398 2,022,093 1,696,881
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (746,154) (622,681) (1,304,104) (1,102,076)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (4,115) 2,272 (6,212) 3,477
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 300 2,332 462 2,992
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (70) 208 29 540
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 111 $ 134 $ 296 $ 145